NSMCE2 Antibody

What is NSMCE2 and what biological functions does it perform?

NSMCE2 (also known as MMS21 in Saccharomyces cerevisiae) is an essential SUMO ligase component of the SMC5/6 complex, which is involved in DNA repair and genome stability maintenance. Research has demonstrated that NSMCE2 suppresses cancer and aging in mice through both SUMO-dependent and SUMO-independent activities . The protein is particularly important for limiting recombination rates and facilitating proper chromosome segregation, functions that are critical for preventing genomic instability . Studies using mouse models have shown that NSMCE2 deficiency leads to pathologies resembling those found in Bloom's syndrome patients, including increased recombination rates and accumulation of micronuclei .

Which tissues typically express NSMCE2 at highest levels?

NSMCE2 expression is most abundant in proliferating tissues. Immunohistochemical analyses have shown distinctively high expression in both human and mouse testis . In mouse embryos, NSMCE2 expression correlates strongly with Ki67-positive (proliferating) regions . In adult tissues, specialized studies using validated antibodies have confirmed high expression in reproductive tissues, with positive immunohistochemical detection specifically reported in mouse testis and ovary tissues . This expression pattern aligns with NSMCE2's roles in processes related to DNA repair and chromosome segregation, which are particularly crucial in rapidly dividing cells.

What are the optimal protocols for using NSMCE2 antibody in Western blot applications?

For optimal Western blot detection of NSMCE2, the recommended dilution range is 1:500-1:2000 for commercially available antibodies such as the 13627-1-AP . Sample preparation should include proper controls, particularly when studying NSMCE2 knockout or knockdown models. Effective Western blot protocols for NSMCE2 typically include:

• Standard protein extraction with protease inhibitors and 20 mM N-ethylmaleimide to preserve SUMOylation status

• Separation on 4-12% gradient SDS-PAGE gels

• Transfer to PVDF or nitrocellulose membranes

• Blocking with 5% non-fat milk or BSA

• Primary antibody incubation overnight at 4°C

• Detection using the LICOR platform for quantitative analysis

The expected molecular weight range is 28-32 kDa, with potential additional higher molecular weight bands representing SUMOylated forms of the protein .

How should NSMCE2 antibody be optimized for immunohistochemistry studies?

For immunohistochemical detection of NSMCE2, researchers should follow these optimization steps:

• Start with a dilution range of 1:50-1:500 as recommended for antibodies such as 13627-1-AP

• For antigen retrieval, use TE buffer at pH 9.0 as the primary method, or alternatively, citrate buffer at pH 6.0

• Validate specificity using appropriate positive control tissues (testis and ovary tissue sections work well for NSMCE2)

• Include negative controls (secondary antibody only and isotype controls)

• Titrate the antibody concentration based on signal-to-noise ratio in your specific tissue of interest

NSMCE2 staining patterns vary depending on the cell type and cell cycle stage. In testis, for example, a distinct NSMCE2 staining pattern is observed in pachytene spermatocytes, coinciding with regions of weak SCP3 signal . This tissue-specific optimization is critical for accurate interpretation of results.

What cell lines are validated for NSMCE2 antibody testing in Western blot applications?

Several human cell lines have been validated for NSMCE2 antibody detection in Western blot applications. According to published validation data, reliable detection has been confirmed in:

• HeLa cells (cervical cancer cell line)

• Jurkat cells (immortalized T lymphocyte line)

• U2OS cells (osteosarcoma cell line)

These cell lines express detectable levels of endogenous NSMCE2 and serve as appropriate positive controls for antibody validation. When establishing NSMCE2 detection in a new cell line, including one of these validated lines as a positive control is recommended for comparison of band patterns and expression levels.

How does NSMCE2 localization change during meiosis and DNA damage response?

NSMCE2 exhibits distinct localization patterns during meiosis that differ from typical DNA damage response proteins. In spermatocyte spreads, NSMCE2 shows no focal staining during the leptotene stage, unlike proteins involved in DNA double-strand break (DSB) repair that show a punctuated pattern . Instead, NSMCE2 displays a distinct staining pattern in pachytene spermatocytes, coinciding with regions of weak SCP3 signal . This localization resembles that of proteins accumulating at regions of incomplete synapsis of meiotic chromosomes, such as BRCA1 .

During DNA damage response in somatic cells, NSMCE2 forms nuclear foci following treatment with DNA-damaging agents like MMS (methyl methanesulfonate). Interestingly, NSMCE2-deficient cells show increased BRCA1 foci formation, indicating elevated recombination activity . This suggests that NSMCE2 plays a regulatory role in limiting recombination events during DNA damage response.

What is the relationship between NSMCE2 and BLM pathways in genomic stability?

NSMCE2 and BLM (Bloom syndrome protein) pathways function independently but show phenotypic similarities when disrupted. In yeast, smc5/6 mutants phenocopy mutations in sgs1, the BLM ortholog deficient in Bloom's syndrome . Similarly, NSMCE2-deficient mice display pathologies resembling those found in Bloom's syndrome patients, including increased recombination rates and micronuclei accumulation .

Despite these similarities, research has shown that NSMCE2 and BLM foci do not colocalize in cells . Furthermore, concomitant deletion of both Blm and Nsmce2 in B lymphocytes leads to further increased recombination rates compared to single deletions and is synthetic lethal due to severe chromosome mis-segregation . This indicates that while both pathways contribute to genomic stability maintenance, they operate through distinct mechanisms, with NSMCE2 performing SUMO- and BLM-independent activities to limit recombination and facilitate chromosome segregation .

How can researchers distinguish between SUMO-dependent and SUMO-independent functions of NSMCE2?

To distinguish between SUMO-dependent and SUMO-independent functions of NSMCE2, researchers can employ the following experimental strategies:

• Comparative mutant analysis: Studies have shown that a mutation compromising NSMCE2-dependent SUMOylation does not detectably impact murine lifespan, whereas complete NSMCE2 deletion leads to severe pathologies . Researchers can use NSMCE2 SUMO ligase-dead mutants (such as C185S/H187A) alongside complete knockouts to differentiate functions.

• SUMOylation assays: Experimental validation can be performed using in vitro or cellular SUMOylation assays. For example, cells expressing wild-type NSMCE2 or NSMCE2 C185S/H187A (SUMO ligase-dead) can be transfected with SUMO1-GFP or FLAG-SUMO2 plasmids, followed by immunoprecipitation and Western blot analysis to assess auto-SUMOylation .

• Phenotypic rescue experiments: Complementation studies using either wild-type NSMCE2 or SUMO ligase-dead mutants in NSMCE2-deficient backgrounds can reveal which cellular phenotypes depend on SUMOylation activity versus structural roles of the protein.

These approaches have revealed that NSMCE2 suppresses cancer and aging through mechanisms that are partially independent of its SUMO ligase activity .

Why might multiple bands be observed when using NSMCE2 antibody in Western blots?

Multiple bands in NSMCE2 Western blots can result from several biological and technical factors:

• Post-translational modifications: NSMCE2 undergoes SUMOylation, which can cause shifts to higher molecular weights. As a SUMO ligase, NSMCE2 can auto-SUMOylate, creating multiple species of different molecular weights .

• Isoforms: Though not extensively documented for NSMCE2, potential alternative splicing could generate multiple protein products.

• Degradation products: Incomplete protease inhibition during sample preparation may lead to partial degradation of NSMCE2, resulting in lower molecular weight bands.

• Cross-reactivity: Non-specific binding of the antibody to other proteins, particularly other components of the SMC5/6 complex.

To distinguish between these possibilities, researchers should:

• Include appropriate controls (NSMCE2 knockout/knockdown)

• Use N-ethylmaleimide (20 mM) during sample preparation to preserve SUMOylated species

• Compare band patterns across different validated cell lines like HeLa, Jurkat, and U2OS

• Perform peptide competition assays to confirm specificity

What controls are essential when studying NSMCE2 in conditional knockout models?

When studying NSMCE2 in conditional knockout models, essential controls include:

• Verification of deletion efficiency: Western blot analysis should confirm the loss of NSMCE2 protein expression after Cre-mediated recombination, as demonstrated in studies using 4-hydroxytamoxifen (4-OHT)-inducible Cre systems .

• Functional validation: Immunofluorescence analyses should confirm the loss of NSMCE2 foci formation in response to DNA damage agents like MMS in knockout cells .

• Phenotypic markers: Sister chromatid exchange (SCE) levels should be measured, as NSMCE2-deficient cells typically show increased SCE even without exogenous damaging agents .

• Time-course analysis: Due to the essential nature of NSMCE2 at the cellular level, as evidenced by clonogenic assays , time-course experiments are necessary to distinguish immediate effects from adaptive responses.

• Tissue-specific considerations: When using tissue-specific Cre drivers, researchers should account for tissue turnover rates and potential selection against deleted cells, as observed in organs with high turnover like the spleen .

These controls ensure reliable interpretation of phenotypes resulting from NSMCE2 deficiency while distinguishing primary effects from secondary consequences.

How should researchers interpret NSMCE2 expression data across different tissue types?

When interpreting NSMCE2 expression data across different tissues, researchers should consider several factors:

• Proliferation status correlation: NSMCE2 expression generally correlates with proliferative activity, being highest in Ki67-positive regions of tissues . Therefore, expression differences may primarily reflect the proliferative index of tissues rather than tissue-specific functions.

• Baseline expression levels: Reproductive tissues, particularly testis, show distinctively high NSMCE2 expression . This establishes a reference point for comparing expression levels in other tissues.

• Cell type heterogeneity: Within complex tissues, NSMCE2 expression may vary significantly between cell types. For example, in testis, specific expression patterns are observed in pachytene spermatocytes .

• Technical considerations: Different detection methods (Western blot, IHC, RT-PCR) may yield varying results. Antibody sensitivity and specificity must be considered, with dilution optimization (1:50-1:500 for IHC, 1:500-1:2000 for WB) performed for each tissue type .

• Functional context: Expression data should be interpreted in the context of known NSMCE2 functions in genomic stability maintenance, particularly in tissues with high replication rates or specialized DNA repair requirements.

By considering these factors, researchers can more accurately interpret variations in NSMCE2 expression across different tissue types and experimental contexts.

What are the implications of NSMCE2 mutations in human disease models?

NSMCE2 mutations have significant implications for human disease models, particularly in relation to cancer, aging, and genome instability syndromes:

• Cancer predisposition: Research indicates that mild deficiencies in the SMC5/6 complex, including NSMCE2, may promote cancer development through increased chromosomal rearrangements arising from elevated recombination rates . Supporting this, NSMCE2 heterozygous mice (Nsmce2+/GT) develop tumors at increased frequency, and SMC5 has been mapped to regions frequently rearranged in human leukemias .

• Accelerated aging phenotypes: More severe NSMCE2 deficiencies lead to accelerated aging phenotypes in mouse models. NSMCE2 deletion in adult mice causes pathologies resembling those found in Bloom's syndrome patients, including reduced percentage of fat, altered pigmentation, and progressive anemia .

• Human patient correlations: Recent reports have identified human patients with reduced NSMCE2 levels who present with dwarfism, altered pigmentation, and increased micronuclei . One such patient died at 33 years from a sudden cardiovascular event, suggesting potential implications for cardiovascular health .

• Mechanistic models: Two potential mechanisms have been proposed for NSMCE2 deficiency-induced progeria: (1) elimination of mutant cells followed by compensatory proliferation, and (2) accumulation of abnormal cells due to inefficient chromosomal segregation, particularly in tissues with lower renewal rates .

These findings suggest that NSMCE2 should be considered in the differential diagnosis of genome instability syndromes and highlight its potential as a therapeutic target for age-related diseases.

How can NSMCE2 antibodies be used to investigate the response to replication stress?

NSMCE2 antibodies can be valuable tools for investigating cellular responses to replication stress through several experimental approaches:

• Foci formation dynamics: Immunofluorescence studies using NSMCE2 antibodies can track the formation, persistence, and resolution of NSMCE2 foci in response to replication stress inducers such as hydroxyurea, aphidicolin, or low-dose MMS . This provides insights into the kinetics of SMC5/6 complex recruitment to stressed replication forks.

• Co-localization studies: Dual immunofluorescence with NSMCE2 antibodies and markers of replication stress (γH2AX, 53BP1, BRCA1) can reveal spatial and temporal relationships between NSMCE2 and other DNA damage response factors. Research has shown that NSMCE2 foci patterns differ from traditional DNA break markers, suggesting specialized functions .

• Chromatin association analysis: Chromatin fractionation followed by Western blot using NSMCE2 antibodies can quantify changes in chromatin association of NSMCE2 during replication stress, providing biochemical evidence of recruitment.

• Proximity ligation assays: Using NSMCE2 antibodies in conjunction with antibodies against replication fork components in proximity ligation assays can identify direct interactions at stressed replication forks.

• ChIP-seq applications: NSMCE2 antibodies can be used for chromatin immunoprecipitation followed by sequencing to map genome-wide binding sites during replication stress, building on findings that SMC5 maps to regions frequently rearranged in human leukemias .

These approaches can provide mechanistic insights into how the SMC5/6 complex responds to replication stress and contributes to genome stability maintenance.